A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- In-vitro Diagnostics Market Worth $133.34 Billion, Globally, by 2027 at 5.1% CAGR: Verified Market Researchon June 24, 2020 at 5:06 am
Verified Market Research recently published a report, "In-vitro Diagnostics Market by Application (Diabetes, Infectious Diseases, ...
- Global Ultrasound Devices Market Analysis (2020 to 2026) - Featuring Esaote, Fujifilm Holdings & GE Healthcare Among Otherson June 24, 2020 at 4:29 am
Ultrasound Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Fastest growing markets analyzed during the ...
- A fidget spinner device for UTI diagnosison June 23, 2020 at 3:40 am
A novel device based on the popular fidget spinner toy has been shown to be effective for point-of-care (POC) diagnosis of UTI and could be useful in low-resource settings. The study has been ...
- ENDRA Life Sciences' NASH Test Device, TAEUS, At Commercialization Inflection Pointon June 19, 2020 at 10:40 pm
TAEUS device fills the need for a non-invasive test for NASH. The device is the only point of care (POC) field diagnostic available. ENDRA is moving forward wit ...
- Global Molecular Diagnostics Market (2020 to 2024) - Insights & Forecast with Potential Impact of COVID-19 - ResearchAndMarkets.comon June 19, 2020 at 9:12 am
The "Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.
- OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomicson June 17, 2020 at 6:17 am
OraSure Technologies, Inc. (OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services is introducing the first and only ...
- 'Optimized for the underserved': A new diagnostic test built for low-income settingson June 17, 2020 at 2:41 am
Hemex Health's Gazelle, a new sickle cell disease test, will roll out in India and Ghana. A focus on diagnostics that function in low-resource contexts could help address a range of global health ...
- Point of Care (PoC) Diagnostics Market Size Estimated to Flourish at USD 34.6 billion by 2025on June 16, 2020 at 12:32 am
According to a new study the global Point of Care (PoC) diagnostics market is anticipated to reach USD 34.6 billion by 2025. Request a sample of this premium report at: By end user, the global Point ...
- In Vitro Diagnostics (IVD) Market Size is Projected to Reach USD 91,093 Million at a CAGR Of 4.8% From 2020 to 2027 - Valuates Reportson June 15, 2020 at 5:38 pm
The global In Vitro Diagnostics Market (IVD) market size was valued at USD 67,111 million in 2019 and is projected to reach USD 91,093 million at a CAGR of 4.8% from 2020 to 2027.
- OTC Drugs, Medical Devices and Diagnostics: Global Marketson June 15, 2020 at 8:48 am
Stock quotes by finanzen.net NEW YORK, June 15, 2020 /PRNewswire/ -- Report Scope: This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global ...
via Bing News